Springe direkt zu Inhalt

VISION 2030 CHANGING PARADIGMS IN INFLAMMATORY BOWEL DISEASES

Jun 10, 2021 - Jun 11, 2021

The TRR241 is a joint research initiative of researchers in Erlangen, Berlin, Kiel and Innsbruck supported by the German Research Foundation (DFG). The TRR241 aims to better understand the molecular and cellular processes that lead to the development of Inflammatory Bowel Diseases (Crohn’s disease and ulcerative colitis), chronic relapsing inflammatory diseases of the gastrointestinal tract.

The TRR241 organizes a virtual meeting on June 10-11, 2021 "VISION 2030 CHANGING PARADIGMS IN INFLAMMATORY BOWEL DISEASES".

Registration is free! Registration Deadline is on June 9, 2021.
Please use this link to register: https://roellmedia-streams.de/vision2030

Confirmed Speakers

Raja Atreya, Universitätsklinikum Erlangen, DE
Natalie Britzen-Laurent, Universitätsklinikum Erlangen, DE
Claudia Günther, Universitätsklinikum Erlangen, DE
Dirk Haller, TUM Technical University of Munich, DE
Iliyan Iliev, Weill Cornell Medicine, New York, USA
Arthur Kaser, University of Cambridge, UK
James Lee, University of Cambridge, UK
Fanny Matheis, The Rockefeller University, New York, USA
Daniel Mucida, The Rockefeller University, New York, USA
Fiona Powrie, University of Oxford, UK
Melanie Schirmer, TUM Technical University of Munich, Freising, DE
Alison Simmons, University of Oxford, UK
Till Strowig, HZI Helmholtz Centre for Infection Research, Braunschweig, DE
Holm Uhlig, University of Oxford, UK
Séverine Vermeire, KU Leuven, BE
Matteo Villa, Max-Plank Institute of Immunobiology and Epigenetics, Freiburg, DE
Rinse Weersma, University of Groningen, NL
Carl Weidinger, Charité – Universitätsmedizin Berlin, DE
Sebastian Winter, UT Southwestern Medical Center, Dallas, USA

Flyer